
### [MONDO:0017674](http://purl.obolibrary.org/obo/MONDO_0017674)
**Label:** disease with focal palmoplantar keratoderma as a major feature

**Subclasses:** [MONDO:0011581](http://purl.obolibrary.org/obo/MONDO_0011581) (dilated cardiomyopathy with woolly hair and keratoderma), [MONDO:0014355](http://purl.obolibrary.org/obo/MONDO_0014355) (cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis), [MONDO:0008173](http://purl.obolibrary.org/obo/MONDO_0008173) (pachyonychia congenita 1), [MONDO:0010160](http://purl.obolibrary.org/obo/MONDO_0010160) (tyrosinemia type II), [MONDO:0014324](http://purl.obolibrary.org/obo/MONDO_0014324) (pachyonychia congenita 3), [MONDO:0008174](http://purl.obolibrary.org/obo/MONDO_0008174) (pachyonychia congenita 2), [MONDO:0014460](http://purl.obolibrary.org/obo/MONDO_0014460) (nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome), [MONDO:0016471](http://purl.obolibrary.org/obo/MONDO_0016471) (pachyonychia congenita), [MONDO:0014492](http://purl.obolibrary.org/obo/MONDO_0014492) (woolly hair-palmoplantar keratoderma syndrome), [MONDO:0007856](http://purl.obolibrary.org/obo/MONDO_0007856) (palmoplantar keratoderma-esophageal carcinoma syndrome), [MONDO:0009827](http://purl.obolibrary.org/obo/MONDO_0009827) (pachyonychia congenita, autosomal recessive), [MONDO:0020095](http://purl.obolibrary.org/obo/MONDO_0020095) (autosomal dominant disease associated with focal palmoplantar keratoderma as a major feature), [MONDO:0020097](http://purl.obolibrary.org/obo/MONDO_0020097) (autosomal recessive disease with focal palmoplantar keratoderma as a major feature), [MONDO:0007860](http://purl.obolibrary.org/obo/MONDO_0007860) (focal palmoplantar and gingival keratoderma), [MONDO:0011884](http://purl.obolibrary.org/obo/MONDO_0011884) (hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome), [MONDO:0014325](http://purl.obolibrary.org/obo/MONDO_0014325) (pachyonychia congenita 4), 

**Mapped go classes:** [GO:0060487](http://purl.obolibrary.org/obo/GO_0060487) (lung epithelial cell differentiation), [GO:0080130](http://purl.obolibrary.org/obo/GO_0080130) (L-phenylalanine:2-oxoglutarate aminotransferase activity), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0005198](http://purl.obolibrary.org/obo/GO_0005198) (structural molecule activity), [GO:0021555](http://purl.obolibrary.org/obo/GO_0021555) (midbrain-hindbrain boundary morphogenesis), [GO:0043069](http://purl.obolibrary.org/obo/GO_0043069) (negative regulation of programmed cell death), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0030307](http://purl.obolibrary.org/obo/GO_0030307) (positive regulation of cell growth), [GO:0006559](http://purl.obolibrary.org/obo/GO_0006559) (L-phenylalanine catabolic process), [GO:0045095](http://purl.obolibrary.org/obo/GO_0045095) (keratin filament), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0003208](http://purl.obolibrary.org/obo/GO_0003208) (cardiac ventricle morphogenesis), [GO:0070563](http://purl.obolibrary.org/obo/GO_0070563) (negative regulation of vitamin D receptor signaling pathway), [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium), [GO:0005882](http://purl.obolibrary.org/obo/GO_0005882) (intermediate filament), [GO:0006572](http://purl.obolibrary.org/obo/GO_0006572) (tyrosine catabolic process), [GO:0014070](http://purl.obolibrary.org/obo/GO_0014070) (response to organic cyclic compound), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0061844](http://purl.obolibrary.org/obo/GO_0061844) (antimicrobial humoral immune response mediated by antimicrobial peptide), [GO:0032836](http://purl.obolibrary.org/obo/GO_0032836) (glomerular basement membrane development), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0051497](http://purl.obolibrary.org/obo/GO_0051497) (negative regulation of stress fiber assembly), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0005911](http://purl.obolibrary.org/obo/GO_0005911) (cell-cell junction), [GO:0002009](http://purl.obolibrary.org/obo/GO_0002009) (morphogenesis of an epithelium), [GO:0001161](http://purl.obolibrary.org/obo/GO_0001161) (intronic transcription regulatory region sequence-specific DNA binding), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0070830](http://purl.obolibrary.org/obo/GO_0070830) (bicellular tight junction assembly), [GO:0016363](http://purl.obolibrary.org/obo/GO_0016363) (nuclear matrix), [GO:0031069](http://purl.obolibrary.org/obo/GO_0031069) (hair follicle morphogenesis), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0032395](http://purl.obolibrary.org/obo/GO_0032395) (MHC class II receptor activity), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0006536](http://purl.obolibrary.org/obo/GO_0006536) (glutamate metabolic process), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0051384](http://purl.obolibrary.org/obo/GO_0051384) (response to glucocorticoid), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0016597](http://purl.obolibrary.org/obo/GO_0016597) (amino acid binding), [GO:0034329](http://purl.obolibrary.org/obo/GO_0034329) (cell junction assembly), [GO:0051546](http://purl.obolibrary.org/obo/GO_0051546) (keratinocyte migration), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0042289](http://purl.obolibrary.org/obo/GO_0042289) (MHC class II protein binding), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0051798](http://purl.obolibrary.org/obo/GO_0051798) (positive regulation of hair follicle development), [GO:0071944](http://purl.obolibrary.org/obo/GO_0071944) (cell periphery), [GO:0060561](http://purl.obolibrary.org/obo/GO_0060561) (apoptotic process involved in morphogenesis), [GO:0021915](http://purl.obolibrary.org/obo/GO_0021915) (neural tube development), [GO:0009074](http://purl.obolibrary.org/obo/GO_0009074) (aromatic amino acid family catabolic process), [GO:0009072](http://purl.obolibrary.org/obo/GO_0009072) (aromatic amino acid family metabolic process), [GO:0045727](http://purl.obolibrary.org/obo/GO_0045727) (positive regulation of translation), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0008544](http://purl.obolibrary.org/obo/GO_0008544) (epidermis development), [GO:0006520](http://purl.obolibrary.org/obo/GO_0006520) (cellular amino acid metabolic process), [GO:0090132](http://purl.obolibrary.org/obo/GO_0090132) (epithelium migration), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0042058](http://purl.obolibrary.org/obo/GO_0042058) (regulation of epidermal growth factor receptor signaling pathway), [GO:0060324](http://purl.obolibrary.org/obo/GO_0060324) (face development), [GO:0042733](http://purl.obolibrary.org/obo/GO_0042733) (embryonic digit morphogenesis), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0042060](http://purl.obolibrary.org/obo/GO_0042060) (wound healing), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0060672](http://purl.obolibrary.org/obo/GO_0060672) (epithelial cell morphogenesis involved in placental branching), [GO:0045617](http://purl.obolibrary.org/obo/GO_0045617) (negative regulation of keratinocyte differentiation), [GO:0003382](http://purl.obolibrary.org/obo/GO_0003382) (epithelial cell morphogenesis), [GO:0005200](http://purl.obolibrary.org/obo/GO_0005200) (structural constituent of cytoskeleton), [GO:0048568](http://purl.obolibrary.org/obo/GO_0048568) (embryonic organ development), [GO:0030216](http://purl.obolibrary.org/obo/GO_0030216) (keratinocyte differentiation), [GO:0051973](http://purl.obolibrary.org/obo/GO_0051973) (positive regulation of telomerase activity), [GO:0072015](http://purl.obolibrary.org/obo/GO_0072015) (glomerular visceral epithelial cell development), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0031424](http://purl.obolibrary.org/obo/GO_0031424) (keratinization), [GO:0030336](http://purl.obolibrary.org/obo/GO_0030336) (negative regulation of cell migration), [GO:0060463](http://purl.obolibrary.org/obo/GO_0060463) (lung lobe morphogenesis), [GO:0030170](http://purl.obolibrary.org/obo/GO_0030170) (pyridoxal phosphate binding), [GO:0008483](http://purl.obolibrary.org/obo/GO_0008483) (transaminase activity), [GO:0045104](http://purl.obolibrary.org/obo/GO_0045104) (intermediate filament cytoskeleton organization), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0009058](http://purl.obolibrary.org/obo/GO_0009058) (biosynthetic process), [GO:0045109](http://purl.obolibrary.org/obo/GO_0045109) (intermediate filament organization), [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier), [GO:0042633](http://purl.obolibrary.org/obo/GO_0042633) (hair cycle), [GO:0006103](http://purl.obolibrary.org/obo/GO_0006103) (2-oxoglutarate metabolic process), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0006979](http://purl.obolibrary.org/obo/GO_0006979) (response to oxidative stress), [GO:0044140](http://purl.obolibrary.org/obo/GO_0044140) (negative regulation of growth of symbiont on or near host surface), [GO:0045111](http://purl.obolibrary.org/obo/GO_0045111) (intermediate filament cytoskeleton), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0004838](http://purl.obolibrary.org/obo/GO_0004838) (L-tyrosine:2-oxoglutarate aminotransferase activity), [GO:0030323](http://purl.obolibrary.org/obo/GO_0030323) (respiratory tube development), [GO:0031490](http://purl.obolibrary.org/obo/GO_0031490) (chromatin DNA binding), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0050709](http://purl.obolibrary.org/obo/GO_0050709) (negative regulation of protein secretion), [GO:0046689](http://purl.obolibrary.org/obo/GO_0046689) (response to mercury ion), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0007568](http://purl.obolibrary.org/obo/GO_0007568) (aging), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0044030](http://purl.obolibrary.org/obo/GO_0044030) (regulation of DNA methylation), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0033147](http://purl.obolibrary.org/obo/GO_0033147) (negative regulation of intracellular estrogen receptor signaling pathway), 

**Class expressions from DL-Learner:**

- Thing 53.78%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.43%
- [GO:0061844](http://purl.obolibrary.org/obo/GO_0061844) (antimicrobial humoral immune response mediated by antimicrobial peptide) 51.43%
- [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier) 51.43%
- [GO:0060672](http://purl.obolibrary.org/obo/GO_0060672) (epithelial cell morphogenesis involved in placental branching) 51.43%
- [GO:0060463](http://purl.obolibrary.org/obo/GO_0060463) (lung lobe morphogenesis) 51.43%
- [GO:0060324](http://purl.obolibrary.org/obo/GO_0060324) (face development) 51.43%
- [GO:0051546](http://purl.obolibrary.org/obo/GO_0051546) (keratinocyte migration) 51.43%
- [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium) 51.43%
- [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis) 51.43%
- [GO:0048704](http://purl.obolibrary.org/obo/GO_0048704) (embryonic skeletal system morphogenesis) 51.43%
- [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis) 51.43%
- [GO:0045095](http://purl.obolibrary.org/obo/GO_0045095) (keratin filament) 51.43%
- [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development) 51.43%
- [GO:0042733](http://purl.obolibrary.org/obo/GO_0042733) (embryonic digit morphogenesis) 51.43%


